However, frail people initiating SGLT-2 inhibitors had a larger absolute rate increase in genital infection but a lower risk for heart failure hospitalisation compared to both GLP-1RA and DPP-4 inhibitors [30]. The gene discussed is SLC5A2; the disease is heart failure.